MSG
IBB icon

Main Street Group’s iShares Biotechnology ETF IBB Stock Holding History

Main Street Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Hold
130
– – 0.01% 406
2026
Q1 		$22K Buy
+130
New +$22.2K 0.01% 429
2025
Q4 		– Sell
-10
Closed -$1.45K – 323
2025
Q3 		$1.45K Hold
10
– – ﹤0.01% 704
2025
Q2 		$1.27K Sell
10
-121
-92% -$14.9K ﹤0.01% 675
2025
Q1 		$16.6K Buy
131
+120
+1,091% +$16.3K 0.01% 436
2024
Q4 		$1.32K Buy
11
+1
+10% +$141 ﹤0.01% 680
2024
Q3 		$1.46K Sell
10
-120
-92% -$17.4K ﹤0.01% 677
2024
Q2 		$17.8K Hold
130
– – 0.01% 426
2024
Q1 		$17.8K Hold
130
– – 0.01% 448
2023
Q4 		$17.7K Buy
+130
New +$15.9K 0.01% 664

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Main Street Group's IBB Position: Q2 2026 in Review

Main Street Group held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 130 shares worth $24.7K. The position accounts for 0.01% of the portfolio, ranked #406.

Main Street Group first reported a position in IBB in Q4 2023 and has held it in 10 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Main Street Group held 130 shares of iShares Biotechnology ETF worth $24.7K as of Q2 2026.
  • Main Street Group left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Main Street Group's portfolio in Q2 2026, its #406 holding.
  • Main Street Group first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 10 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.